Abstract:Circulation: Genomic and Precision Medicine, Ahead of Print. Background:Predictive performance of polygenic risk scores (PRS) varies across populations. To facilitate equitable clinical use, we developed PRS for coronary heart disease (CHD; PRSCHD) for 5 genetic ancestry groups.Methods:We derived ancestry-specific and multi-ancestry PRSCHDbased on pruning and thresholding and continuous shrinkage priors (polygenic risk score for CHD developed using ancestry-based continuous shrinkage methods) applied to summary statistics from the largest multi-ancestry genome-wide association study meta-analysis for CHD to date, including 1.1 million participants from 5 major genetic ancestry groups. Following training and optimization in the Million Veteran Program, we evaluated the best-performing PRSCHDin 176 988 individuals across 9 diverse cohorts.Results:Multi-ancestry polygenic risk score for CHD developed using pruning and thresholding methods and polygenic risk score for CHD developed using ancestry-based continuous shrinkage methods outperformed ancestry-specific Polygenic risk score for CHD developed using pruning and thresholding methods and polygenic risk score for CHD developed using ancestry-based continuous shrinkage methods across a range of tuning values. Two best-performing multi-ancestry PRSCHD(ie, polygenic risk score for CHD developed using pruning and thresholding methods optimized using a multi-ancestry population and polygenic risk score for CHD developed using ancestry-based continuous shrinkage methods optimized using a multi-ancestry population) and 1 ancestry-specific (PRSCSxEUR) were taken forward for validation. Polygenic risk score for CHD developed using pruning and thresholding methods (PT) optimized using a multi-ancestry population demonstrated the strongest association with CHD in individuals of South Asian genetic ancestry and European genetic ancestry (odds ratio per 1 SD [95% CI, 2.75 [2.41–3.14], 1.65 [1.59–1.72]), followed by East Asian genetic ancestry (1.56 [1.50–1.61]), Hispanic/Latino genetic ancestry (1.38 [1.24–1.54]), and African genetic ancestry (1.16 [1.11–1.21]). Polygenic risk score for CHD developed using ancestry-based continuous shrinkage methods optimized using a multi-ancestry population showed the strongest associations in South Asian genetic ancestry (2.67 [2.38–3.00]) and European genetic ancestry (1.65 [1.59–1.71]), lower in East Asian genetic ancestry (1.59 [1.54–1.64]), Hispanic/Latino genetic ancestry (1.51 [1.35–1.69]), and the lowest in African genetic ancestry (1.20 [1.15–1.26]).Conclusions:The use of summary statistics from a large multi-ancestry genome-wide meta-analysis improved the performance of PRSCHDin most ancestry groups compared with single-ancestry methods. Despite the use of one of the largest and most diverse sets of training and validation cohorts to date, improvement of predictive performance was limited in African genetic ancestry. This highlights the need for larger Genome-wide association study datasets of underrepresented populations to enhance the performance of PRSCHD.

An Integrated Germline and Somatic Genomic Model Improves Risk Prediction for Coronary Artery Disease

A Large-Scale Multi-Ethnic Genome-Wide Association Study of Coronary Artery Disease

Large-scale genome-wide association study of coronary artery disease in genetically diverse populations

Abstract 16592: A Next-Generation Artificial Intelligence-Based Integrated Genetic-Epigenetic Prediction of 5-Year Risk for Coronary Heart Disease

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.

A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease

Genetic loci associated with prevalent and incident myocardial infarction and coronary heart disease in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium

A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study

Polygenic Risk, Rare Variants, and Family History: Independent and Additive Effects on Coronary Heart Disease

Clinical and Genomic Prediction of Coronary Artery Disease Subtypes

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.

Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization

Rare variant contribution to the heritability of coronary artery disease

A Comprehensive 1000 Genomes-based Genome-Wide Association Meta-Analysis of Coronary Artery Disease

Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease

Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: Evidence from the China Kadoorie Biobank

Epigenetic Contributions to Clinical Risk Prediction of Cardiovascular Disease

Multi-ancestry Genome-Wide Study Identifies Effector Genes and Druggable Pathways for Coronary Artery Calcification

Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

Serum lipid levels, body mass index, and their role in coronary artery calcification: a polygenic analysis